Use of nucleic acid base compound in preparing medicinal biodegradation material and method of preparing medicinal biodegradation material

The present invention relates to the use of biodegradable materials, and methods of using biologically degradable materials nucleic acid base compound prepared in the preparation of pharmaceutical medicine. The method uses a non-toxic, non-nucleic acid base metal compound catalyst is a ring-based monomer ring-opening polymerization or copolymerization reaction, to synthesize a high degree of biometric security pharmaceutical biodegradable material.